These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 32748700)
1. Targeting Colorectal Cancer Stem Cells as an Effective Treatment for Colorectal Cancer. Ma YS; Li W; Liu Y; Shi Y; Lin QL; Fu D Technol Cancer Res Treat; 2020; 19():1533033819892261. PubMed ID: 32748700 [TBL] [Abstract][Full Text] [Related]
2. CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines. Muraro MG; Mele V; Däster S; Han J; Heberer M; Cesare Spagnoli G; Iezzi G Stem Cells Transl Med; 2012 Aug; 1(8):592-603. PubMed ID: 23197865 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer. Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640 [TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice. Wang D; Fu L; Sun H; Guo L; DuBois RN Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008 [TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor. Huang R; Wang G; Song Y; Tang Q; You Q; Liu Z; Chen Y; Zhang Q; Li J; Muhammand S; Wang X Mol Med Rep; 2015 Aug; 12(2):2417-24. PubMed ID: 25936357 [TBL] [Abstract][Full Text] [Related]
6. Characterization of cancer stem cells from different grades of human colorectal cancer. Manhas J; Bhattacharya A; Agrawal SK; Gupta B; Das P; Deo SV; Pal S; Sen S Tumour Biol; 2016 Oct; 37(10):14069-14081. PubMed ID: 27507615 [TBL] [Abstract][Full Text] [Related]
7. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target. Yan Y; Zuo X; Wei D Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504 [TBL] [Abstract][Full Text] [Related]
8. Colon cancer stem cells: Potential target for the treatment of colorectal cancer. Gupta R; Bhatt LK; Johnston TP; Prabhavalkar KS Cancer Biol Ther; 2019; 20(8):1068-1082. PubMed ID: 31050577 [TBL] [Abstract][Full Text] [Related]
9. Targeting cancer stem-like cells in glioblastoma and colorectal cancer through metabolic pathways. Kahlert UD; Mooney SM; Natsumeda M; Steiger HJ; Maciaczyk J Int J Cancer; 2017 Jan; 140(1):10-22. PubMed ID: 27389307 [TBL] [Abstract][Full Text] [Related]
10. SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells. Hwang WL; Yang MH; Tsai ML; Lan HY; Su SH; Chang SC; Teng HW; Yang SH; Lan YT; Chiou SH; Wang HW Gastroenterology; 2011 Jul; 141(1):279-91, 291.e1-5. PubMed ID: 21640118 [TBL] [Abstract][Full Text] [Related]
11. Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer. Wu W; Cao J; Ji Z; Wang J; Jiang T; Ding H Oncotarget; 2016 Dec; 7(49):81144-81155. PubMed ID: 27835894 [TBL] [Abstract][Full Text] [Related]
12. Targeting cancer stem cells as therapeutic approach in the treatment of colorectal cancer. Parizadeh SM; Jafarzadeh-Esfehani R; Hassanian SM; Parizadeh SMR; Vojdani S; Ghandehari M; Ghazaghi A; Khazaei M; Shahidsales S; Rezayi M; Asgharzadeh F; Ghayour-Mobarhan M; Ferns GA; Avan A Int J Biochem Cell Biol; 2019 May; 110():75-83. PubMed ID: 30818083 [TBL] [Abstract][Full Text] [Related]
13. Resveratrol Chemosensitizes TNF-β-Induced Survival of 5-FU-Treated Colorectal Cancer Cells. Buhrmann C; Yazdi M; Popper B; Shayan P; Goel A; Aggarwal BB; Shakibaei M Nutrients; 2018 Jul; 10(7):. PubMed ID: 30002278 [No Abstract] [Full Text] [Related]
14. USP47 maintains the stemness of colorectal cancer cells and is inhibited by parthenolide. Zhang S; Ju X; Yang Q; Zhu Y; Fan D; Su G; Kong L; Li Y Biochem Biophys Res Commun; 2021 Jul; 562():21-28. PubMed ID: 34030041 [TBL] [Abstract][Full Text] [Related]
15. Cancer stem cells in colorectal cancer from pathogenesis to therapy: controversies and perspectives. Fanali C; Lucchetti D; Farina M; Corbi M; Cufino V; Cittadini A; Sgambato A World J Gastroenterol; 2014 Jan; 20(4):923-42. PubMed ID: 24574766 [TBL] [Abstract][Full Text] [Related]
16. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells. Shi L; Xi J; Xu X; Peng B; Zhang B Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544 [TBL] [Abstract][Full Text] [Related]
17. Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer. Song L; Li Y; He B; Gong Y Clin Colorectal Cancer; 2015 Sep; 14(3):133-45. PubMed ID: 25799881 [TBL] [Abstract][Full Text] [Related]
18. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer. Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827 [TBL] [Abstract][Full Text] [Related]
19. The Role of Tumor Stem Cells in Colorectal Cancer Drug Resistance. Zhong C; Wang G; Guo M; Zhu N; Chen X; Yan Y; Li N; Yu W Cancer Control; 2024; 31():10732748241274196. PubMed ID: 39215442 [No Abstract] [Full Text] [Related]
20. Targeting the SPHK1/HIF1 Pathway to Inhibit Colorectal Cancer Stem Cells Niche. Khoei SG; Sadeghi H; Dermani FK J Gastrointest Cancer; 2020 Jun; 51(2):716-717. PubMed ID: 31093935 [No Abstract] [Full Text] [Related] [Next] [New Search]